Mesoblast rebounds 40 per cent after regulator approval
MELBOURNE: Stem cell treatment producer Mesoblast has recorded a significant win after the US FDA’s
MELBOURNE: Stem cell treatment producer Mesoblast has recorded a significant win after the US FDA’s